SPRY4 and clear cell renal carcinoma: Notably, the results from TCGA databases also indicated that the upregulated SPRY4-IT1 expression may be closely relevant to poor overall survival in clear cell renal cell carcinoma and glioma (P < 0.001), which partially identified our results in this meta-analysis.